Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Journal of Medical Economics|March 9, 2026
A systematic literature review of methodologies used in economic evaluations of combination vaccinesManuela Di Fusco, Shailja Vaghela, Ceu Mateus, et al.
Pharmaceutical Statistics|February 26, 2026
Assessment of Responder Analyses for Patient-Reported Outcomes With Varying Variability Between Intervention Groups: Maximum Responder Threshold and EffectJoseph C Cappelleri, Jia Ma, Manuela Di Fusco, et al.
Healthcare (Basel, Switzerland)|August 29, 2024
Caregiver Burden among Patients with Influenza or Influenza-like Illness (ILI): A Systematic Literature ReviewShailja Vaghela, Verna L Welch, Anup Sinh, et al.
Journal of Medical Economics|January 22, 2026
Incorporating underreporting of epidemiological burden in COVID-19 models: a targeted literature reviewIshveen Chopra, Jingyan Yang, Alon Yehoshua, et al.
Journal of Medical Economics|March 21, 2023
Public health impact and economic value of booster vaccination with Pfizer-BioNTech COVID-19 vaccine, bivalent (Original and Omicron BA.4/BA.5) in the United StatesManuela Di Fusco, Kinga Marczell, Elizabeth Thoburn, et al.
Journal of Medical Economics|October 6, 2020
Utilization of anticoagulants and predictors of treatment among hospitalized patients with atrial fibrillation in the USASteven Deitelzweig, Amol D Dhamane, Manuela Di Fusco, et al.
Current Medical Research and Opinion|March 9, 2021
Real-world persistence to direct oral anticoagulants in patients with atrial fibrillation: a systematic review and network meta-analysisSteven Deitelzweig, Manuela Di Fusco, Amiee Kang, et al.
Journal of Medical Economics|November 13, 2024
Public health and economic impact of COVID-19 vaccination with the Pfizer-BioNTech COVID-19 Vaccine, KP.2, among adults in 2024/2025 in the United StatesAlon Yehoshua, Manuela Di Fusco, Abby E Rudolph, et al.
Health and Quality of Life Outcomes|September 7, 2023
Assessment of retrospective collection of EQ-5D-5L in a US COVID-19 populationXiaowu Sun, Manuela Di Fusco, Laura Puzniak, et al.
Journal of Medical Economics|March 27, 2026
Cost-effectiveness, public health impact, and budget impact of receipt of Pfizer-BioNTech COVID-19 vaccine, LP.8.1-adapted, 2025/2026 formula among adults aged 18 years and older at high risk for severe outcomes from COVID-19 in the United StatesAlon Yehoshua, Manuela Di Fusco, Abby E Rudolph, et al.
Pageof 7